Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paraneoplastic Neurological Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableStudy completedNCT05783947
What this trial is testing

Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies

Who this might be right for
Paraneoplastic Neurological SyndromeAutoimmune Encephalitis
Hospices Civils de Lyon 34
Not applicableUnknownNCT03957616
What this trial is testing

Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis

Who this might be right for
Paraneoplastic Neurological SyndromeAutoimmune Encephalitis
Hospices Civils de Lyon 600
Post-approval studies (Phase 4)Study completedNCT00179478
What this trial is testing

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Who this might be right for
Multiple SclerosisOptic NeuritisTransverse Myelitis+1 more
Beth Israel Deaconess Medical Center 155
Not applicableUnknownNCT03963700
What this trial is testing

Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)

Who this might be right for
CancerParaneoplastic SyndromesNeurologic Disorder+2 more
Hospices Civils de Lyon 980
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Not applicableStudy completedNCT05645185
What this trial is testing

Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient

Who this might be right for
Autoimmune EncephalitisParaneoplastic Syndromes
Hospices Civils de Lyon 43
Large-scale testing (Phase 3)Study completedNCT01868269
What this trial is testing

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Who this might be right for
Opsoclonus Myoclonus SyndromeNeuroblastoma
Institut Curie 102
Not applicableStudy completedNCT00587106
What this trial is testing

Studies of Neurological Paraneoplastic Syndromes

Who this might be right for
Paraneoplastic Neurologic Degenerations (PNDs)
Memorial Sloan Kettering Cancer Center 51
Not applicableLooking for participantsNCT06502015
What this trial is testing

Biomarkers in Autoimmune Disease of Nervous System

Who this might be right for
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple Sclerosis+8 more
Tongji Hospital 50,000
Not applicableStudy completedNCT03490539
What this trial is testing

Disease-Modifying Treatments for Myasthenia Gravis

Who this might be right for
Neurological DisorderAutoimmune Diseases
Duke University 82
Very early researchLooking for participantsNCT06939166
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia GravisMultiple Sclerosis+2 more
Tianjin Huanhu Hospital 12
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Not applicableStudy completedNCT04678115
What this trial is testing

Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

Who this might be right for
BlepharoptosisPtosis, EyelidMyasthenia Gravis+3 more
Massachusetts Eye and Ear Infirmary 16
Not applicableLooking for participantsNCT04698421
What this trial is testing

Collection of Biological Samples From Patients With Rare Neurological Diseases

Who this might be right for
Nervous System Diseases
University Hospital, Toulouse 1,000
Not applicableEnded earlyNCT00004682
What this trial is testing

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
University of Texas 100
Not applicableEnrolling By InvitationNCT00704626
What this trial is testing

Serum Auto-Antibodies in Neurological Diseases

Who this might be right for
Multiple SclerosisMyasthenia GravisTransverse Myelitis
University of California, Davis 120
Large-scale testing (Phase 3)Study completedNCT05737160
What this trial is testing

Study of Telitacicept in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
RemeGen Co., Ltd. 114
Not applicableStudy completedNCT00806182
What this trial is testing

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

Who this might be right for
Opsoclonus-myoclonus Syndrome
National Pediatric Neuroinflammation Organization, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT02591901
What this trial is testing

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

Who this might be right for
UTINeurogenic BladderAntibiotic Resistance
Buckinghamshire Healthcare NHS Trust 48
Next Page